Should I buy or sell Alliance Pharma stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alliance Pharma in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" APH shares. View APH analyst ratings or view top-rated stocks .

What is Alliance Pharma's stock price target for 2024?

4 equities research analysts have issued 1 year target prices for Alliance Pharma's stock. Their APH share price targets range from GBX 53 to GBX 105. On average, they predict the company's stock price to reach GBX 80.75 in the next twelve months. This suggests a possible upside of 116.8% from the stock's current price. View analysts price targets for APH or view top-rated stocks among Wall Street analysts .

How have APH shares performed in 2024?

Alliance Pharma's stock was trading at GBX 40.50 at the beginning of the year. Since then, APH stock has decreased by 8.0% and is now trading at GBX 37.25. View the best growth stocks for 2024 here .

Is Alliance Pharma a good dividend stock?

Alliance Pharma (LON:APH) pays an annual dividend of GBX 2 per share and currently has a dividend yield of 3.75%. Read our dividend analysis for APH .

What other stocks do shareholders of Alliance Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Alliance Pharma investors own include RPC Group (RPC) , American Airlines Group (AAL) , BlackBerry (BB) , Editas Medicine (EDIT) , 1-800-FLOWERS.COM (FLWS) , Air Canada (AC) , Ally Financial (ALLY) , Aviva (AV) , BAE Systems (BA) and Berry Global Group (BERY) .

How do I buy shares of Alliance Pharma?

Shares of APH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:APH

Alliance Pharma (APH) Share Price, News & Analysis

→ The #1 Investment of the Decade… (From Porter & Company) (Ad)

Free APH Stock Alerts

GBX 37.44

+0.19 (+0.50%)

(As of 05:26 AM ET)

Compare

Today's Range: 37
▼
38.40
50-Day Range: 36.35
▼
44.80
52-Week Range: 33.70
▼
73.04

Volume: 44,130 shs
Average Volume: 765,769 shs
Market Capitalization: £202.31 million

P/E Ratio: N/A
Dividend Yield: 5.34%
Price Target: GBX 80.75

Stock Analysis Analyst Forecasts Chart Competitors Dividend Headlines Insider Trades

Get Alliance Pharma alerts:

Alliance Pharma MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.75 Rating Score
Upside/Downside: 116.8% Upside
GBX 80.75 Price Target
Short Interest: N/A
Dividend Strength: Weak
Based on Four Factors
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.41 out of 5 stars

3.4

Analyst's Opinion

Consensus Rating
Alliance Pharma has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.
Amount of Analyst Coverage
Alliance Pharma has only been the subject of 1 research reports in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for APH.

1.7

Dividend Strength

Dividend Leadership
Alliance Pharma is a leading dividend payer. It pays a dividend yield of 3.75%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Alliance Pharma does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for APH.

0.6

News and Social Media Coverage

Search Interest
14 people have searched for APH on MarketBeat in the last 30 days. This is an increase of 17% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Alliance Pharma insiders have not sold or bought any company stock.
Percentage Held by Insiders
11.74% of the stock of Alliance Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
71.04% of the stock of Alliance Pharma is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Alliance Pharma is -3,725.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Alliance Pharma is -3,725.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Growth Ratio
Alliance Pharma has a PEG Ratio of 1.04. PEG Ratios around 1 indicate that a company is correctly valued.
Price to Book Value per Share Ratio
Alliance Pharma has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

Click here to see the details.

About Alliance Pharma Stock (LON:APH)

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics. It provides its products under the Aloclair, Anbesol, Asthon and Parsons, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. Alliance Pharma plc was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom.

APH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

APH Stock News Headlines

April 16, 2024 | americanbankingnews.com

Alliance Pharma (LON:APH) Shares Cross Below 200-Day Moving Average of $39.04

February 5, 2024 | msn.com

Healthcare firm Alliance Pharma appoints new chair

April 16, 2024 | InvestorPlace (Ad)

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

January 31, 2024 | lse.co.uk

LONDON BROKER RATINGS: Jefferies raises Spirax-Sarco; cuts Victrex

January 15, 2024 | finance.yahoo.com

Investors in Alliance Pharma (LON:APH) have unfortunately lost 52% over the last three years

November 30, 2023 | markets.businessinsider.com

Ascendis Pharma’s Growth Potential Bolstered by Strategic Partnership and Product Pipeline

November 23, 2023 | morningstar.com

Alliance Pharma PLC APH

November 11, 2023 | uk.investing.com

Alliance Pharma (ALAPH)

April 16, 2024 | InvestorPlace (Ad)

“Forget Tesla, this is Elon’s Next Big Thing”

According to Forbes, this breakthrough could define the future of AI. Most people don’t know about it… Because it was found 750 miles away from Silicon Valley.

October 19, 2023 | finance.yahoo.com

Calculating The Intrinsic Value Of Alliance Pharma plc (LON:APH)

June 2, 2023 | fool.co.uk

Should you invest in Mark Slater favourite Alliance Pharma right now?

May 28, 2023 | msn.com

Numis Reiterates Alliance Pharma (LSE:APH) Buy Recommendation

March 24, 2023 | finance.yahoo.com

Earnings Miss: Alliance Pharma plc Missed EPS By 95% And Analysts Are Revising Their Forecasts

March 18, 2023 | fool.co.uk

3 dirt cheap growth shares to buy right now?

February 9, 2023 | finance.yahoo.com

Alliance Pharma plc's (LON:APH) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?

January 19, 2023 | finance.yahoo.com

Is Alliance Pharma plc (LON:APH) Trading At A 49% Discount?

December 3, 2022 | finance.yahoo.com

Alliance Pharma plc (LON:APH) is a favorite amongst institutional investors who own 85%

October 24, 2022 | finance.yahoo.com

Shareholders in Alliance Pharma (LON:APH) are in the red if they invested a year ago

September 20, 2022 | finance.yahoo.com

Edited Transcript of ALAPH.L earnings conference call or presentation 20-Sep-22 8:30am GMT

September 7, 2022 | apnews.com

Love Pharma Initiates First Steps Towards a Strategic Alliance with Starton Therapeutics with Investment in this Biotech Leader

September 2, 2022 | fool.co.uk

Alliance Pharma

September 2, 2022 | finance.yahoo.com

Are Alliance Pharma plc's (LON:APH) Mixed Financials Driving The Negative Sentiment?

August 13, 2022 | marketwatch.com

U.S. Alliance Pharma Expands Early Phase Bioanalytical Services Into Australia

August 8, 2022 | marketwatch.com

Alliance Pharma Names New Auditor After KPMG Resigns Over Corporate Concerns

June 2, 2022 | uk.finance.yahoo.com

The Alliance Pharma share price – where next?

May 16, 2022 | finance.yahoo.com

Investors in Alliance Pharma (LON:APH) have made a solid return of 148% over the past five years

May 14, 2022 | fool.co.uk

7 top AIM market shares to buy now

See More Headlines

Receive APH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alliance Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Drug Manufacturers - Specialty & Generic
Sub-Industry: N/A
Current Symbol: LON:APH
CUSIP: N/A
CIK: N/A
Web: www.alliancepharma.co.uk
Phone: +44-1249-466966
Fax: N/A
Employees: 285
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: GBX 80.75
High Stock Price Target: GBX 105
Low Stock Price Target: GBX 53
Potential Upside/Downside: +116.8%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.75
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): GBX (0.01)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 8.40
P/E Growth: 1.04
Net Income: £-7,060,000.00
Net Margins: -4.15%
Pretax Margin: N/A
Return on Equity: -2.46%
Return on Assets: 2.99%

Debt

Debt-to-Equity Ratio: 45.00
Current Ratio: 1.93
Quick Ratio: 1.42

Sales & Book Value

Annual Sales: £170.05 million
Price / Sales: 1.18
Cash Flow: GBX 4.73 per share
Price / Cash Flow: 7.87
Book Value: GBX 51 per share
Price / Book: 0.73

Miscellaneous

Outstanding Shares: 540,400,000
Free Float: N/A
Market Cap: £201.30 million
Optionable: Not Optionable
Beta: 0.60

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. Andrew Timothy Franklin (Age 58)
Interim CEO, CFO & Executive Director
Comp: $271.52k
Mr. Peter Jonathan Butterfield (Age 48)
CEO & Executive Director (Leave of Absence)
Comp: $399.83k
Mr. Jeyan Heper (Hons) (Age 50)
BA, COO & Director
Mr. Stephen Kidner
Chief Scientific Affairs Officer
Ms. Cora Maeve McCallum C.F.A.
Head of Investor Relations & Corporate Communications
Mr. Christodoulos Theoclis Chrysanthou
Group General Counsel & Company Secretary
Mr. Alex Duggan
Chief Commercial & Corporate Development Officer
Julie Skinner
Chief People Officer
Chris Delafield
Global Marketing Head of Kelo-Cote
Rhodri Smith
Head of Sourcing

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

APH Stock Analysis - Frequently Asked Questions

Should I buy or sell Alliance Pharma stock right now?: 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Alliance Pharma in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" APH shares.
View APH analyst ratings or view top-rated stocks.
What is Alliance Pharma's stock price target for 2024?: 4 equities research analysts have issued 1 year target prices for Alliance Pharma's stock. Their APH share price targets range from GBX 53 to GBX 105. On average, they predict the company's stock price to reach GBX 80.75 in the next twelve months. This suggests a possible upside of 116.8% from the stock's current price.
View analysts price targets for APH or view top-rated stocks among Wall Street analysts.
How have APH shares performed in 2024?: Alliance Pharma's stock was trading at GBX 40.50 at the beginning of the year. Since then, APH stock has decreased by 8.0% and is now trading at GBX 37.25.
View the best growth stocks for 2024 here.
Is Alliance Pharma a good dividend stock?: Alliance Pharma (LON:APH) pays an annual dividend of GBX 2 per share and currently has a dividend yield of 3.75%.
Read our dividend analysis for APH.

What other stocks do shareholders of Alliance Pharma own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Alliance Pharma investors own include RPC Group (RPC), American Airlines Group (AAL), BlackBerry (BB), Editas Medicine (EDIT), 1-800-FLOWERS.COM (FLWS), Air Canada (AC), Ally Financial (ALLY), Aviva (AV), BAE Systems (BA) and Berry Global Group (BERY).
How do I buy shares of Alliance Pharma?: Shares of APH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:APH) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Alliance Pharma (APH) Share Price, News & Analysis

Alliance Pharma MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

Search Interest

Company Ownership

Earnings and Valuation

About Alliance Pharma Stock (LON:APH)

APH Stock Price History

APH Stock News Headlines

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

APH Stock Analysis - Frequently Asked Questions

Overall MarketRank^™